Transatrial Implantation of the Sapien 3 Heart Valve in Severe Mitral Annular Calcification: Multi-Clinic Experience, Written and Video Description

ABSTRACT

There is growing interest in using transcatheter valve therapy to address mitral valve disease in the setting of severe mitral annular calcification (MAC). Using the Sapien XT or Sapien 3 transcatheter heart valve has produced promising results when implanted from a percutaneous transseptal approach and from a surgical transatrial approach. However, there is lack of technical support for these cases from the transatrial side. Our group has a large experience using the Sapien valve for this purpose and have used a specific technique with excellent results. Here we present a step-by-step presentation of the technique in video detail.

KEYWORDS:

• Transcatheter
• transcatheter aortic valve replacement
• mitral
• mitral annular calcification
• mitral valve replacement

Disclosure statement

Issac George is a consultant for Edwards Lifescience and Medtronic. Vinayak Bapat is a consultant to Edwards Lifesciences, Medtronic Inc, Abbott, 4Tech and Boston Scientific. Dr Borger has received speaking fees from Edwards Lifesciences. The remaining authors declare no conflict of interest related to this work.

Supplemental data

Supplemental data for this article can be accessed here.